Genetic Contributions to the Development of Complications in Preterm Newborns

PLoS One. 2015 Jul 14;10(7):e0131741. doi: 10.1371/journal.pone.0131741. eCollection 2015.

Abstract

Aim: We aimed to identify specific polymorphisms of genes encoding for vascular endothelial growth factor A (VEGFA), endothelial nitric oxide synthase (eNOS), renin-angiotensin system (angiotensinogen gene [AGT], angiotensinogen type 1 receptor [AGTR1], angiotensin-converting enzyme [ACE]), and heme oxygenase-1 (HMOX-1) in a cohort of preterm infants and correlate their presence with the development of respiratory distress syndrome (RDS) requiring mechanical ventilation (MV), bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH) and retinopathy of prematurity (ROP).

Study design: We carried out a retrospective study to evaluate the allele frequency and genotype distribution of polymorphisms of VEGFA, eNOS, AGT, AGTR1, ACE, and HMOX-1 in a population of preterm neonates (n=342) with a gestational age ≤28 weeks according to the presence or absence of RDS requiring MV, BPD, IVH, or ROP. Moreover, we evaluated through the haplotype reconstruction analysis whether combinations of the selected polymorphisms are related to the occurrence of RDS, BPD, IVH and ROP.

Results: In our population 157 infants developed RDS requiring MV, 71 BPD, 70 IVH, and 43 ROP. We found that TC+CC rs2070744 eNOS (41.7 vs. 25.4%, p=0.01) and GT+TT rs1799983 eNOS (51.8 vs. 35.2%, p=0.01) polymorphisms are independent risk factors for BPD. Haplotype reconstruction showed that haplotypes in VEGF and eNOS are significantly associated with different effects on RDS, BPD, IVH, and ROP in our population.

Conclusions: We found that TC+CC rs2070744 eNOS and GT+TT rs1799983 eNOS polymorphisms are independent predictors of an increased risk of developing BPD. Haplotypes of VEGFA and eNOS may be independent protective or risk markers for prematurity complications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensinogen / genetics
  • Bronchopulmonary Dysplasia / complications
  • Cohort Studies
  • Female
  • Gene Frequency
  • Genotype
  • Heme Oxygenase-1 / genetics
  • Humans
  • Infant, Newborn
  • Intracranial Hemorrhages / complications
  • Male
  • Nitric Oxide Synthase Type III / genetics
  • Peptidyl-Dipeptidase A / genetics
  • Polymorphism, Single Nucleotide*
  • Pregnancy
  • Premature Birth / enzymology
  • Premature Birth / genetics*
  • Premature Birth / therapy
  • Receptor, Angiotensin, Type 1 / genetics
  • Respiration, Artificial
  • Respiratory Distress Syndrome, Newborn / complications
  • Retinopathy of Prematurity / complications
  • Retrospective Studies
  • Vascular Endothelial Growth Factor A / genetics

Substances

  • AGT protein, human
  • AGTR1 protein, human
  • Receptor, Angiotensin, Type 1
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Angiotensinogen
  • Nitric Oxide Synthase Type III
  • HMOX1 protein, human
  • Heme Oxygenase-1
  • Peptidyl-Dipeptidase A

Supplementary concepts

  • Respiratory Distress Syndrome In Premature Infants

Grants and funding

The study was funded by Ente Cassa di Risparmio di Firenze to Fiorgen Foundation, Florence, Italy.